Recent Advances and Perspectives in Cancer Drug Design

Irena      Kostova

doi:10.2174/138161282922230822111237

[1]
Moazamiyanfar R, Rezaei S, Ashrafzadeh HA, et al. Nobiletin in cancer therapy; mechanisms and therapy perspectives. Curr Pharm Des  2023; 29(22): 1713-28.

[2]
Katiyar S, Jin XH, Yadav D. Red Seaweed-derived compounds: A desired approach for treating cancer. Curr Pharm Des  2023; 29(22): 1729-40.

[3]
Hamilton G, Stickler S, Rath B. Targeting of SOS1: from SOS1 activators to proteolysis targeting chimeras. Curr Pharm Des  2023; 29(22): 1741-6.

[4]
Akitsu T, Tsvetkova D, Yamamoto Y, Nakane D, Kostova I. From basics of coordination chemistry to understanding cisplatin-analogue Pt drugs. Curr Pharm Des  2023; 29(22): 1747-74.

[5]
Ravuluri JAV, Rao V, Kumar G, et al. Brain-targeted nano-architectures for efficient drug delivery and sensitization in glioblastoma. Curr Pharm Des  2023; 29(22): 1775-90.

[6]
Serrano-Pindado A, Iorhemba MA, Díaz-García D, et al. Cytotoxic and DNA-binding capacity of titanocene functionalized mesoporous nanoparticles in breast cancer cell lines MCF-7 and MDA-MB-231. Curr Pharm Des  2023; 29(22): 1791-9.

Rights & Permissions Print Cite

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/138161282922230822111237	Print ISSN 1381-6128
Publisher Name Bentham Science Publisher	Online ISSN 1873-4286

Current Pharmaceutical Design

Recent Advances and Perspectives in Cancer Drug Design

Related Journals

Related Books